pmc logo image
Logo of bmjBMJ helping doctors make better decisionsSearchLatest content
Journal List > BMJ > v.307(6904); Sep 4, 1993

Formats:
BMJ. 1993 September 4; 307(6904): 575–576.
PMCID: PMC1678944
Copyright notice
Iron and coronary heart disease.
M J Burt, J W Halliday, and L W Powell
Small right arrow pointing to: See letter "Iron and coronary heart disease. Control for haematological variables." on page 1067.
Small right arrow pointing to: See letter "Iron and coronary heart disease. Iron makes myocardium vulnerable to ischemia." on page 1066.
Small right arrow pointing to: See letter "Iron and coronary heart disease. Iron linked to immune activation." on page 1067.
 
Small right arrow pointing to: This article has been cited by other articles in PMC.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (467K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 575
575
icon of scanned page 576
576
 
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Sullivan JL. The iron paradigm of ischemic heart disease. Am Heart J. 1989 May;117(5):1177–1188. [PubMed]
  • Lauffer RB. Iron stores and the international variation in mortality from coronary artery disease. Med Hypotheses. 1991 Jun;35(2):96–102. [PubMed]
  • Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 1992 Sep;86(3):803–811. [PubMed]
  • Leggett BA, Brown NN, Bryant SJ, Duplock L, Powell LW, Halliday JW. Factors affecting the concentrations of ferritin in serum in a healthy Australian population. Clin Chem. 1990 Jul;36(7):1350–1355. [PubMed]
  • Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989 Apr 6;320(14):915–924. [PubMed]
  • Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W, Witztum JL. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 1992 Apr 11;339(8798):883–887. [PubMed]
  • Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7725–7729. [PubMed]
  • Riemersma RA, Wood DA, Macintyre CC, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet. 1991 Jan 5;337(8732):1–5. [PubMed]
  • Halliwell B. Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis. Br J Exp Pathol. 1989 Dec;70(6):737–757. [PubMed]
  • Williams RE, Zweier JL, Flaherty JT. Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts. Circulation. 1991 Mar;83(3):1006–1014. [PubMed]
Articles from BMJ : British Medical Journal are provided here courtesy of
BMJ Publishing Group

PubMed articles by these authors

Recent Activity